About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,539 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,539 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 7341-7360 of 7,539 trials

Active not recruitingObserving the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate CancerObjectives of Study： Primary Objective: To observe and evaluate the safety of abiraterone acetate tablets (II) and conventional abiraterone tablets in patients with metastatic…NCT07721532·Nanjing Completed131-I-TM-601 Study in Adults With Solid TumorsThis study is designed to evaluate the ability of intravenously (IV)administered 131-I-labeled TM-601 (chlorotoxin) to provide tumor-specific localization(via radiographic…NCT00379132·Birmingham, Alabama and 5 others

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingAddressing Health Literacy With a Tailored Survivorship Care PlanThis clinical trial compares the impact of a tailored survivorship care plan (SCP) to a standard SCP on the understanding of and access to survivorship care in black or African…NCT06674863·Atlanta, Georgia and 2 others

RecruitingPSMA PET for Surveillance After Focal TherapyThis study is about adding PSMA PET (Prostate Specific Membrane Antigen- Positron Emission Tomography) to routine magnetic resonance imaging (MRI) scans to help detect prostate…NCT07115914·Chicago, Illinois

TerminatedAssessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to TherapyThe study is an open label, non-randomized study designed to evaluate the diagnostic performance of SPECT CT.NCT03619655·Baltimore, Maryland and 1 other

CompletedLycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate CancerRATIONALE: The use of lycopene, a substance found in tomatoes, or omega-3 fatty acid nutritional supplements may keep cancer from growing in patients with prostate cancer.NCT00402285·San Francisco, California

WithdrawnAMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)The goal of this clinical research study is learn how AMG208 may help to control prostate cancer that has spread to the bone. The safety of the drug will also be studied.NCT02420587·Houston, Texas

Not yet recruitingImpact of Body Composition on Dosimetry of 177Lu-PSMA Radioligand TherapyCOCORIVO is an interventional study evaluating the impact of body composition on dosimetry of 177Lu-PSMA radioligand therapy in patients with metastatic castration-resistant…NCT07587814·Rouen, Normanie

CompletedVaccine Therapy Plus QS21 in Treating Patients With Prostate CancerRATIONALE: Vaccines may make the body build an immune response to kill tumor cells.NCT00036933·New York, New York

CompletedVaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate CancerBackground: * Flutamide is an approved drug for prostate cancer that blocks the effects of testosterone on prostate cancer cells and may slow the progression of the disease.NCT00450463·Bethesda, Maryland and 2 others

WithdrawnImpact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the ProstateBenign prostatic hyperplasia(BPH) is a common disease in urology among old men.NCT02822963·Tainan

CompletedEffectiveness of Open and Robotic ProstatectomyProstate cancer is the most common cancer in American men. Surgical removal of the entire prostate (prostatectomy) is one option among the various ways to treat prostate cancer.NCT01325506·San Francisco, California and 8 others

RecruitingSAFE Nerve Sparing Guided by Micro-ultrasound (MUS)Robotic-assisted radical prostatectomy (RALP) has become the standard of care in the management of localized prostate cancer.NCT06945315·New York, New York

CompletedHealth-related Quality of Life, Psychological Distress and Fatigue in Metastatic CRPC Patients Treated With Radium-223The aim of the current prospective multicenter study is to evaluate cancer-specific and bone metastases related HR-QoL, psychological distress and fatigue in mCRPC patients…NCT04995614·'s-Hertogenbosch and 10 others

CompletedTrial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate CancerPRIMARY OBJECTIVES: Determination of safety and toxicity of vaccination with mRNA transfected DC (based on blood samples, and adverse events).NCT01278914·Oslo

UnknownExpression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate CancerAs prostate cancer progresses, tumor cells dissociate and enter the bloodstream.NCT02723526·Shanghai, Shanghai Municipality

Not yet recruitingRISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)This is a prospective, interventional, non-randomized, phase 2 study to assess oncologic outcomes of metastatic hormone-sensitive prostate cancer (mCSPC) patients who receive a…NCT07645326·Washington D.C., District of Columbia

RecruitingFocal Therapy for Localized Prostate CancerThis prospective registry and longitudinal study that is designed to carefully measure details of prostate cancer patients' outcomes with focal therapy.NCT06270043·La Jolla, California

Active not recruitingEBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate CancerThis study is trying to find out if the combination of Androgen deprivation therapy (ADT), MRI guided high dose radiation (HDR) brachytherapy treatment (internal radiation implant…NCT04465500·Charlottesville, Virginia

CompletedSystemic and Tumor-Directed Therapy for Oligometastatic Prostate CancerThis is a trial for patients with newly diagnosed metastatic prostate cancer with 5 or fewer sites of metastases.NCT03298087·Long Beach, California and 2 others

PreviousPage 368 of 377Next